Literature DB >> 19403764

The first vancomycin-intermediate Staphylococcus aureus strains isolated from patients in Thailand.

Aroonlug Lulitanond1, Chulapan Engchanil, Prajuab Chaimanee, Malai Vorachit, Teruyo Ito, Keiichi Hiramatsu.   

Abstract

We screened 533 and 361 methicillin (meticillin)-resistant Staphylococcus aureus strains isolated in a university hospital in 2002 and 2003 and in 2006 and 2007, respectively, and identified 4 (0.8%) of the strains in the first group and 8 (2.2%) of the strains in second group as heterogeneous vancomycin-resistant S. aureus (heterogeneous VISA) strains and 3 (0.8%) of the strains in the second group as VISA strains. This is the first report of VISA strains isolated from patients in Thailand.

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19403764      PMCID： PMC2708526          DOI： 10.1128/JCM.01749-08

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  33 in total

1.  Heterogeneous resistance to vancomycin in Staphylococcus aureus.

Authors:  R A Howe; M Wootton; T R Walsh; P M Bennett; A P Macgowan
Journal:  J Antimicrob Chemother       Date:  2000-01       Impact factor: 5.790

2.  Dissemination in Japanese hospitals of strains of Staphylococcus aureus heterogeneously resistant to vancomycin.

Authors:  K Hiramatsu; N Aritaka; H Hanaki; S Kawasaki; Y Hosoda; S Hori; Y Fukuchi; I Kobayashi
Journal:  Lancet       Date:  1997-12-06       Impact factor: 79.321

3.  Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility.

Authors:  K Hiramatsu; H Hanaki; T Ino; K Yabuta; T Oguri; F C Tenover
Journal:  J Antimicrob Chemother       Date:  1997-07       Impact factor: 5.790

4.  Bacteremia caused by staphylococci with inducible vancomycin heteroresistance.

Authors:  S S Wong; P L Ho; P C Woo; K Y Yuen
Journal:  Clin Infect Dis       Date:  1999-10       Impact factor: 9.079

Review 5.  Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing.

Authors:  F C Tenover; R D Arbeit; R V Goering; P A Mickelsen; B E Murray; D H Persing; B Swaminathan
Journal:  J Clin Microbiol       Date:  1995-09       Impact factor: 5.948

Review 6.  Vancomycin-resistant Staphylococcus aureus: a new model of antibiotic resistance.

Authors:  K Hiramatsu
Journal:  Lancet Infect Dis       Date:  2001-10       Impact factor: 25.071

7.  Bacteremia due to Staphylococcus aureus with reduced susceptibility to vancomycin.

Authors:  S S Wong; T K Ng; W C Yam; D N Tsang; P C Woo; S K Fung; K Y Yuen
Journal:  Diagn Microbiol Infect Dis       Date:  2000-04       Impact factor: 2.803

8.  Prevalence of agr specificity groups among Staphylococcus aureus strains colonizing children and their guardians.

Authors:  B Shopsin; B Mathema; P Alcabes; B Said-Salim; G Lina; A Matsuka; J Martinez; B N Kreiswirth
Journal:  J Clin Microbiol       Date:  2003-01       Impact factor: 5.948

9.  Effects of antibiotic-diuretic interactions in the guinea pig model of ototoxicity.

Authors:  R E Brummett
Journal:  Rev Infect Dis       Date:  1981 Nov-Dec

10.  Epidemiological and microbiological characterization of infections caused by Staphylococcus aureus with reduced susceptibility to vancomycin, United States, 1997-2001.

Authors:  Scott K Fridkin; Jeff Hageman; Linda K McDougal; Jasmine Mohammed; William R Jarvis; Trish M Perl; Fred C Tenover
Journal:  Clin Infect Dis       Date:  2003-01-31       Impact factor: 9.079
View more
  8 in total

Review 1.  Systematic review and meta-analysis of the significance of heterogeneous vancomycin-intermediate Staphylococcus aureus isolates.

Authors:  Sebastiaan J van Hal; David L Paterson
Journal:  Antimicrob Agents Chemother       Date:  2010-11-15       Impact factor: 5.191

2.  Comprehensive identification of mutations responsible for heterogeneous vancomycin-intermediate Staphylococcus aureus (hVISA)-to-VISA conversion in laboratory-generated VISA strains derived from hVISA clinical strain Mu3.

Authors:  Miki Matsuo; Longzhu Cui; Jeeyoung Kim; Keiichi Hiramatsu
Journal:  Antimicrob Agents Chemother       Date:  2013-09-09       Impact factor: 5.191

3.  Impact of rpoB mutations on reduced vancomycin susceptibility in Staphylococcus aureus.

Authors:  Yukiko Watanabe; Longzhu Cui; Yuki Katayama; Kishii Kozue; Keiichi Hiramatsu
Journal:  J Clin Microbiol       Date:  2011-04-27       Impact factor: 5.948

4.  Cartography of methicillin-resistant S. aureus transcripts: detection, orientation and temporal expression during growth phase and stress conditions.

Authors:  Marie Beaume; David Hernandez; Laurent Farinelli; Cécile Deluen; Patrick Linder; Christine Gaspin; Pascale Romby; Jacques Schrenzel; Patrice Francois
Journal:  PLoS One       Date:  2010-05-20       Impact factor: 3.240

5.  A mutation in the PP2C phosphatase gene in a Staphylococcus aureus USA300 clinical isolate with reduced susceptibility to vancomycin and daptomycin.

Authors:  Karla D Passalacqua; Sarah W Satola; Emily K Crispell; Timothy D Read
Journal:  Antimicrob Agents Chemother       Date:  2012-07-30       Impact factor: 5.191

6.  Dissecting vancomycin-intermediate resistance in staphylococcus aureus using genome-wide association.

Authors:  Md Tauqeer Alam; Robert A Petit; Emily K Crispell; Timothy A Thornton; Karen N Conneely; Yunxuan Jiang; Sarah W Satola; Timothy D Read
Journal:  Genome Biol Evol       Date:  2014-04-30       Impact factor: 3.416

7.  Global prevalence and distribution of vancomycin resistant, vancomycin intermediate and heterogeneously vancomycin intermediate Staphylococcus aureus clinical isolates: a systematic review and meta-analysis.

Authors:  Aref Shariati; Masoud Dadashi; Majid Taati Moghadam; Alex van Belkum; Somayeh Yaslianifard; Davood Darban-Sarokhalil
Journal:  Sci Rep       Date:  2020-07-29       Impact factor: 4.379

Review 8.  Systematic Review and Meta-Analysis of the Epidemiology of Vancomycin-Intermediate and Heterogeneous Vancomycin-Intermediate Staphylococcus aureus Isolates.

Authors:  Shanshan Zhang; Xiaoxi Sun; Wenjiao Chang; Yuanyuan Dai; Xiaoling Ma
Journal:  PLoS One       Date:  2015-08-19       Impact factor: 3.240
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.